With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.

Eli Lilly's (LLY) fourth quarter and full-year earnings mostly met Wall Street estimates but missed expectations for sales of its weight loss GLP-1 drugs Mounjaro and Zepbound.

Eli Lilly’s profit doubled in the fourth quarter ... easily topping the $5.01 that Wall Street was looking for, according to a poll of industry analysts by FactSet. Mounjaro and Zepbound ...

Eli Lilly's (LLY) fourth quarter and full-year earnings mostly met Wall Street estimates but missed expectations for sales of its weight loss GLP-1 drugs Mounjaro and Zepbound. Mizuho healthcare ...

Eli Lilly and Company LLY will release its fourth-quarter financial results, before the opening bell, on Thursday, Feb. 6, 2025. Analysts expect the Indianapolis, Indiana-based company to report ...

Eli Lilly LLY-N on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing investor agitation about signs of weakness in sales of the drugs.

The Pulitzer Prize-winning play “English” opened ... “I’m not here to say art can save us — but without art, we’re gonna die.” Also on the new episode of “Stagecraft,” Toossi ...

The Pulitzer Prize-winning play “English” opened on Broadway ... “We live in a really tricky moment right now,” Toossi added. “I’m not here to say art can save us — but without art, we’re gonna die.” ...

Given this perspective, it's time to examine the average forecasts of specific Lilly metrics that are routinely monitored and predicted by Wall Street analysts. Based on the collective assessment ...